Germany Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big new investments from Merck and Bayer, the implications of the country’s new Digital Healthcare Act, the impact of the coronavirus outbreak on investor sentiment, and the health minister potentially poised to become Germany’s…
Mexico Juan de Villafranca, executive director of the Asociacion Mexicana de Laboratorios Farmaceuticos (AMELAF), shares the exciting new initiatives he has launched in the past two years of his term; the importance and strength of AMELAF as the representative association of 44 100 percent Mexican-owned pharmaceutical manufacturers; and the potential and…
Belgium Over the past few decades, pharma multinationals have been increasingly drawn to the highly cost-competitive markets of Central Eastern Europe (CEE) and Asia to situate major manufacturing sites. However, despite a comparatively expensive location, Belgium’s strong industrial heritage and manufacturing expertise is helping to maintain the country as a strategic…
Belgium Paul Herijgers, dean of the faculty of medicine at leading Belgian university KU Leuven, outlines the collaborative research projects the university is undertaking and its role within the wider Belgian innovation ecosystem. [KU Leuven] is actually the most innovative university in Europe according to Reuters Rankings thanks to our…
Romania Valentina Băicuianu and Adrian Grecu of the APMGR, share their insights on the deteriorating environment for generics in Romania, with unfavourable pricing methodology and a rising and an unpredictable clawback tax. They reveal the solutions that the generics industry has proposed to authorities and outline their continued endeavours to convince…
Czech Republic Martin Minarovič, Janssen’s country director Czech Republic, discusses the success factors behind the company’s strong growth, not only in terms of revenue but more importantly in terms of the number of patients treated. Moreover, he highlights Janssen’s transformation to become a more customer- and patient-centric organization, the progress and areas…
Romania Schalk Opperman, general manager of Merck Romania explains the key factors behind successful product launches in what is an unpredictable market. He shares his insights on Merck’s impressive growth in Romania and navigating the intricacies of the country’s pricing policy. In addition, he discloses advice for newcomers and reveals the…
Generics Arun Narayan of Medicines for Europe’s Value Added Medicines Group has been working to promote the benefits of value added medicines and how real-world evidence must be considered. In a recent interview with PharmaBoardroom he elaborated on what some countries are already doing to adopt Value Added Medicines and the…
Belgium There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause of death without a reversal of current trends. Against this backdrop, the European Commission is launching the ‘Europe’s Beating Cancer Plan’ to reduce…
UAE Pharmax, a Dubai-based manufacturer and distributor of generic medications, is aiming to shake up the UAE’s healthcare system with its affordable and high-quality medications. CEO Madhukar Tanna highlights the recent EU GMP approval of its manufacturing plant and explains the overall impact that generic medications can have in reducing costs…
Europe An overview of the types of new medicines recommended for approval by the European Medicines Agency (EMA) in 2019. Made with Visme Infographic Maker A full list of the medicines recommended for approval by the EMA in 2019 Made with Visme Infographic Maker
UAE Elis Pharmaceuticals, a company that develops, manufactures and markets branded products and over the counter generic medications, continues to gain ground in the Middle East thanks to its distinctive approach. CEO Rashed Assouma takes us through the creation process of the company in the 2000s, how Elis has fostered collaboration…
See our Cookie Privacy Policy Here